NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
CLARITY PHARMACEUTICALS LTD (AU: CU6)
CU6 Technical Analysis
4
As on 11th Jul 2023 CU6 STOCK Price closed @ 0.81 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.64 & Strong Buy for SHORT-TERM with Stoploss of 0.64 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CU6STOCK Price
Open | 0.77 | Change | Price | % |
High | 0.84 | 1 Day | 0.05 | 6.58 |
Low | 0.77 | 1 Week | 0.11 | 15.71 |
Close | 0.81 | 1 Month | 0.03 | 3.85 |
Volume | 198802 | 1 Year | 0.11 | 15.71 |
52 Week High 1.00 | 52 Week Low 0.38 |
AU Australia Most Active Stocks
MOB | 0.02 | 100.00% |
SI6 | 0.01 | % |
GMN | 0.01 | 0.00% |
LPD | 0.01 | 0.00% |
LDX | 0.06 | -14.29% |
S32 | 3.69 | 3.65% |
WWI | 0.02 | 100.00% |
HWK | 0.09 | % |
SYA | 0.19 | 5.56% |
G88 | 0.05 | -16.67% |
AU Australia Top Gainers Stocks
AU Australia Top Losers Stocks
CU6 Daily Charts |
CU6 Intraday Charts |
Whats New @ Bazaartrend |
CU6 Free Analysis |
|
CU6 Important Levels Intraday
RESISTANCE | 0.94 |
RESISTANCE | 0.90 |
RESISTANCE | 0.87 |
RESISTANCE | 0.85 |
SUPPORT | 0.77 |
SUPPORT | 0.75 |
SUPPORT | 0.72 |
SUPPORT | 0.68 |
CU6 Forecast May 2024
4th UP Forecast | 1.35 |
3rd UP Forecast | 1.18 |
2nd UP Forecast | 1.07 |
1st UP Forecast | 0.96 |
1st DOWN Forecast | 0.66 |
2nd DOWN Forecast | 0.55 |
3rd DOWN Forecast | 0.44 |
4th DOWN Forecast | 0.27 |
CU6 Weekly Forecast
4th UP Forecast | 0.98 |
3rd UP Forecast | 0.93 |
2nd UP Forecast | 0.89 |
1st UP Forecast | 0.86 |
1st DOWN Forecast | 0.76 |
2nd DOWN Forecast | 0.73 |
3rd DOWN Forecast | 0.69 |
4th DOWN Forecast | 0.64 |
CU6 Forecast2024
4th UP Forecast | 2.14 |
3rd UP Forecast | 1.71 |
2nd UP Forecast | 1.45 |
1st UP Forecast | 1.19 |
1st DOWN Forecast | 0.43 |
2nd DOWN Forecast | 0.17 |
3rd DOWN Forecast | -0.09 |
4th DOWN Forecast | -0.52 |
CLARITY PHARMACEUTICALS LTD ( AU Australia Symbol : CU6 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CU6 Other Details
Segment | EQ | |
Market Capital | 285588288.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
CU6 Address
CU6 Latest News
CU6 Business Profile
Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, develops theranostic therapy and imaging products for the treatment of cancer in children and adults. Its lead product is SARTATE, a targeted theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express somatostatin receptor 2. The company is also developing SAR-Bombesin, a pan cancer theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express gastrin releasing peptide receptor; and SAR-bisPSMA, a theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express prostate specific membrane antigen. The company was incorporated in 2010 and is headquartered in Sydney, Australia. Address:
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service